Many mucins were abnormally expressed in adenocarcinomas and were associated with carcinogenesis, tumor invasion, and prognosis, as mentioned before, and we selected MUC20 (fold change =1.577, P = 0.005, Table 1) as a newly recognized biomarker to investigate its role in CRC. Here, MUC20 is linked to adenocarcinoma.